Get startedLog in
    Picture of Matinas BioPharma Holdings logo

    MTNB — Matinas BioPharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Matinas Biopharma Holdings Says Under Agreement With Biontech, Co Will Receive Exclusivity Fee Of $2.75 Mln

    Picture of Matinas BioPharma Holdings logoMatinas BioPharma Holdings
    11/04/2022 12:16
    April 11 (Reuters) - Matinas BioPharma Holdings Inc
 MTNB.A :
    * MATINAS BIOPHARMA HOLDINGS- UNDER TERMS OF COLLABORATION
AGREEMENT WITH BIONTECH, CO WILL RECEIVE EXCLUSIVITY FEE IN THE
AMOUNT OF $2.75 MILLION

Further company coverage:  MTNB.A 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Matinas BioPharma Holdings

    See all news